Cardinal Inks Deal to Sell Contract Manufacturing Unit

Cardinal Health (Dublin, OH) says it has signed a definitive agreement to sell most of its pharma technologies and services (PTS) contract manufacturing business to private equity firm The Blackstone Group (New York) for approximately $3.3 billion. The deal is expected to close early in the fiscal fourth quarter, ending June 30, and is subject to customary closing conditions, including regulatory approval. Cardinal Health announced plans to sell its PTS business late last year to focus resources on the company’s four other segments, which offer services to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers